A computer model estimates how much chemotherapy-driven aging could cost breast cancer survivors

A simulation of 400 million women, fed with human measurements of a marker of worn-out cells, projects that harsher chemotherapy for breast cancer may bring forward deaths from other causes by years, even as it improves survival from the cancer itself. These are model estimates resting on several assumptions, not outcomes observed in real patients.

Observational study in people

Cells that grow too big may stop dividing because of one mis-edited message

Human cells kept from dividing while they kept growing became oversized and stopped dividing for good. In these cells, the message for MDM4, a brake on the cell's emergency stop, was edited wrongly; giving the cells a correct copy let many of them divide again. It is a laboratory study in one human cell line and a not yet peer-reviewed preprint.

Cells in the lab

A protein that fades with age kept blood-vessel cells young in the lab, in mice and in worms

The protein MTR4 dwindles as the cells lining blood vessels age. Adding it back made aged human cells in a dish look younger, boosting it in the vessel lining of old mice eased signs of aging in their vessels and organs, and extra MTR4 made worms live much longer. This is early lab and animal work with small groups of mice; nothing here has been tested in people.

Animal study